Shares of Sorin Group (BIT:SRN) and Cyberonics (NSDQ:CYBX) jumped today after the medical device companies said the way is clear for the consummation of their $2.7 billion merger. Sorin said a Milan court dismissed a claim brought by an Italian state attorney seeking to prevent Sorin from dodging a $3.76 billion environmental lawsuit filed against […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Ex-KCI chief Burzik bows out of Palmaz Scientific
Cathy Burzik, the former CEO of Kinetic Concepts Inc., is no longer slated to take the helm at Palmaz Scientific, the company co-founded by coronary stent pioneer Dr. Julio Palmaz in 2008, Palmaz told MassDevice.com today. “We essentially decided not to do the deal because we just didn’t agree,” Palmaz told us in a brief telephone […]
EXCLUSIVE: Palmaz Scientific, out of cash, taps ex-KCI CEO Burzik
UPDATED August 17, 2015, 5 p.m., with comment from Julio Palmaz. Palmaz Scientific, the company co-founded by coronary stent pioneer Dr. Julio Palmaz in 2008, is out of cash and looking for a new CEO, according to a letter to shareholders obtained by MassDevice.com. Julio Palmaz plans to step down from his chairman’s role at Palmaz Scientific, […]
Abiomed seeks expanded PMAs for Impella heart pump line
Abiomed (NSDQ:ABMD) said today it submitted PMA applications to expand indications for its Impella line of percutaneous micro heart pumps to patients suffering cardiogenic shock following acute myocardial infarction or cardiac surgery. In addition to the new indication, the Danvers, Mass.-based company also submitted an application for longer duration use, Abiomed said. The submissions include a […]
Abiomed bullish on 5-year strategy, pipeline products
Abiomed (NSDQ:ABMD) yesterday released 5-year financial growth plans as well as preliminary information on new pipeline products. The full presentation of the company’s long-term growth strategy and vision was presented to investors yesterday in Abiomed’s annual investor conference in Boston. The company’s plans call for $1.2-$1.8 billion in sales, significantly higher than analyst estimates, according […]
Biotronik launches 2 new studies
Biotronik announced 2 new studies last week that are slated to examine the company’s CRT-D device and BioMonitor implanted cardiac monitor. A 277-patient BioContinue clinical trial will examine the risk of ventricular arrhythmias after CRT-D replacement, enrolling patients over 2 years at 40 centers across 8 countries, the company said. Biotronik said the trial will […]
Study: Edwards’ Sapien and Medtronic’s CoreValve outcomes are similar
A new study published in the Journal of the American College of Cardiology found that patients treated with Edwards Lifesciences‘s (NYSE:EW) and Medtronic‘s (NYSE:MDT) CoreValve showed similar results after 1 year. The 241-patient trial examined high-risk patients with symptomatic severe aortic stenosis 1 year after being treated with either Edwards’s Sapien balloon expanding or Medtronic’ self-expanding […]
Abiomed partners with Fenway Park
Abiomed (NSDQ:ABMD) said today it entered into a corporate partnership with Boston’s Fenway Park, and will bring its Impella mobile learning lab to the stadium tomorrow. The lab will be parked at Fenway so individuals in healthcare and medical fields can learn about its Impella heart pump, which the Danvers, Mass.-based company says is the […]
HeartWare completes enrollment in Endurance2 HVAD trial
HeartWare International (NSDQ:HTWR) said today it completed enrollment of its Endurance 2 destination therapy trial of its HeartWare ventricular assist system. The trial seeks to examine the rate of stroke in patients treated with HeartWare’s HVAD device as well as optimal blood pressure management, the company said. Data from the 465-patient supplemental cohort trial will be […]
Glaukos iStent wins nod from Health Canada
Glaukos (NYSE:GKOS) said today it won approval from Health Canada for its iStent Inject trabecular micro-bypass stent designed for use in cataract surgeries to treat glaucoma. The newly cleared iStent inject is indicated for micro-invasive glaucoma surgery procedures to reduce intraocular pressure in patients with primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma, the Laguna Hills, […]
JenaValve closes $27m Series C round
JenaValve Technology said today that it closed a $26.5 million Series C round for the replacement heart valve it’s developing. Irvine, Calif.-based JenaValve said the round was co-led by RMM (Rudi Mariën) and Valiance and included existing backers Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management and VI Partners. The proceeds are earmarked […]